Little T - I appreciate that you may not be at liberty to divulge info from private conversations but I do have two questions if you are happy to indulge.
1. What is your sense of which way Jon and the team want to take this show - are they looking to progress solo or with minimal support and become the next CSL? Are they looking to licence 2591 similar to Acadia deal? Are they looking to a genuine partnership with a big pharma to progress this jointly? Are they positioning for a complete sale? What is your gut feel?
2. What timeframe do you think this will all unfold in? What timeframe will we have clarity around the future direction?
Appreciate you may not be able to divulge and/or wish to divulge but would appreciate your thoughts.
Thanks
Little T - I appreciate that you may not be at liberty to...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.70 |
Change
0.520(2.71%) |
Mkt cap ! $2.515B | |||
| Open | High | Low | Value | Volume |
| $19.39 | $19.84 | $19.28 | $5.675M | 288.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1531 | $19.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.81 | 557 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.70 |
Change
0.520 ( 2.59 %) |
||||
| Open | High | Low | Volume | ||
| $19.50 | $19.84 | $19.28 | 87628 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| NEU (ASX) Chart |